12:00 AM
 | 
Sep 10, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Abilify aripiprazole regulatory update

Otsuka said it submitted an application in Japan to expand the label of Abilify aripiprazole to include the adjunctive treatment for major depressive disorder...

Read the full 97 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >